Clinical Outcomes of Patients With Metastatic NSCLC After Discontinuation of Immunotherapy Because of Immune-Related Adverse Effects.
JTO Clin Res Rep
; 4(1): 100441, 2023 Jan.
Article
in En
| MEDLINE
| ID: mdl-36578272
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Observational_studies
Language:
En
Journal:
JTO Clin Res Rep
Year:
2023
Type:
Article
Affiliation country:
Netherlands